Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Immunomodulatory Nanomedicine.

Matthias Bartneck1

  • 1Department of Medicine III, Medical Faculty, RWTH Aachen, Pauwelsstr. 30, 52074, Aachen, Germany.

Macromolecular Bioscience
|April 7, 2017
PubMed
Summary

Nanomedicine offers a promising alternative to biologics for treating inflammatory diseases and cancer by targeting immune cells. This approach, particularly focusing on macrophages, represents a potential breakthrough in immunotherapy.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Alcohol consumption in metabolic dysfunction-associated steatotic liver disease (MASLD): understanding the gut-liver crosstalk for clinical translation.

Gut microbes·2026
Same author

Distinct effector functions and synergy of CAR mRNA-engineered T cells and macrophages in the clearance of CD19<sup>+</sup> leukemia cells.

Journal of advanced research·2026
Same author

Nonhematopoietic MicroRNA-26b<sup>-/-</sup> Augments Atherosclerosis Development by Increasing Endothelial Inflammation and Leukocyte Adhesion-Brief Report.

Arteriosclerosis, thrombosis, and vascular biology·2025
Same author

MicroRNA-26b-/- augments atherosclerosis, while mimic-loaded nanoparticles reduce atherogenesis.

Cardiovascular research·2025
Same author

Stratification of Hepatocellular Carcinoma Using <i>N</i><sup>6</sup>-Methyladenosine.

Cancers·2025
Same author

Remote Control of Eukaryotic Gene Expression by a Modular Ultrasound-Responsive RNA Toolkit.

Angewandte Chemie (International ed. in English)·2025

Area of Science:

  • Immunology
  • Nanomedicine
  • Oncology

Background:

  • Immune system modulation is crucial for treating inflammatory diseases and cancer.
  • Biologics targeting immune cells represent a significant market, but nanomedicine offers a potential alternative.
  • Macrophages are a key focus for future breakthroughs in innate immune cell modulation.

Purpose of the Study:

  • To review the role of immune cells in disease.
  • To summarize current biologic and small molecule therapies.
  • To present novel nanomedicine-based immunotherapies, including their opportunities and risks.

Main Methods:

  • Literature review of immune cell involvement in disease.
  • Summary of existing biologic and small molecule therapies.
Keywords:
biologicsdrug deliveryimmune cellsleukocytesmacrophagesnanocarriersnanomedicinepolymerssmall molecules

Related Experiment Videos

  • Analysis of emerging nanomedicine-based immunotherapies.

    • Main Results:

    • Adaptive leukocytes are currently used in cancer immunotherapy.
    • Macrophage-targeted therapies are anticipated as the next major advancement.
    • Nanomedicine presents a viable alternative to therapeutic proteins as biologic patents expire.

    Conclusions:

    • Nanomedicine holds significant potential to revolutionize immunotherapy for cancer and inflammatory diseases.
    • Understanding the interplay of immune cells is key to developing effective treatments.
    • Emerging nanomedicine strategies require careful consideration of both benefits and risks.